Director at Guardant Health (GH) exercises 154 RSUs and holds 19,362 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Guardant Health, Inc. director Steve E. Krognes exercised restricted stock units into common stock in a routine compensation-related transaction. On April 30, 2026, 154 common shares were acquired upon RSU vesting, bringing his direct common stock holdings to 19,362 shares.

The RSUs originated from an award granted on August 9, 2022, with 25% vesting on June 30, 2023 and the remaining 75% vesting in substantially equal monthly installments over three years. After this vesting event, he holds 309 restricted stock units directly.

Insider Trade Summary

154 shares exercised/converted

Mixed 2 txns

Insider Krognes Steve E.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	154	$0.00	--
Exercise	Common Stock	154	$0.00	--

Holdings After Transaction: Restricted Stock Units — 309 shares (Direct, null); Common Stock — 19,362 shares (Direct, null)

Footnotes (1)

This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and as to the remaining 75% of the shares subject to such award vests in substantially equal installments each month during the three-year period thereafter. Not applicable for Restricted Stock Units.

Key Figures

RSUs exercised: 154 shares Common shares held after transaction: 19,362 shares RSUs remaining: 309 units +3 more

6 metrics

RSUs exercised 154 shares Restricted Stock Units converted to common stock on April 30, 2026

Common shares held after transaction 19,362 shares Direct Guardant Health common stock holdings after RSU exercise

RSUs remaining 309 units Restricted Stock Units directly held after April 30, 2026 vesting

Exercise transactions 1 exercise, 154 shares Transaction summary exerciseCount and exerciseShares

RSU grant date August 9, 2022 Original restricted stock unit award grant date

Initial vesting tranche 25% of award Vested on June 30, 2023 from August 9, 2022 RSU grant

Key Terms

Restricted Stock Units, Exercise or conversion of derivative security, Form 4

3 terms

Restricted Stock Units financial

"This represents a restricted stock unit award granted on August 9, 2022."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/01/2026 - 05:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krognes Steve E.

(Last)

(First)

(Middle)

3100 HANOVER STREET

(Street)

PALO ALTO

CALIFORNIA

94304

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		M		154	A	$0	19,362	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	04/30/2026		M			154	⁽¹⁾	⁽²⁾	Common Stock	154	$0	309	D

Explanation of Responses:

1. This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and as to the remaining 75% of the shares subject to such award vests in substantially equal installments each month during the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John Saia, as attorney-in-fact for Steve Krognes	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Guardant Health (GH) director Steve Krognes report in this Form 4?

Steve Krognes reported exercising restricted stock units into common stock. On April 30, 2026, 154 Guardant Health shares were acquired from RSU vesting, reflecting routine equity compensation rather than an open-market purchase or sale.

How many Guardant Health shares does Steve Krognes hold after this transaction?

After the April 30, 2026 RSU vesting, Steve Krognes directly holds 19,362 shares of Guardant Health common stock. This figure reflects his position following the conversion of 154 restricted stock units into common shares.

How many restricted stock units does Steve Krognes still hold at Guardant Health (GH)?

Following the April 30, 2026 vesting event, Steve Krognes directly holds 309 restricted stock units. These RSUs continue to vest according to the original award schedule granted on August 9, 2022, subject to the plan’s terms.

Was this Guardant Health Form 4 a stock purchase or sale by Steve Krognes?

The Form 4 reflects an exercise of restricted stock units, not an open-market buy or sell. Code “M” indicates a derivative exercise or conversion, where 154 RSUs converted into common stock at a stated price of $0.00 per share.

What is the vesting schedule for Steve Krognes’ Guardant Health RSU award?

The RSU award was granted on August 9, 2022. Twenty-five percent vested on June 30, 2023, with the remaining 75% scheduled to vest in substantially equal monthly installments over the following three-year period, subject to applicable conditions.

Does this Guardant Health Form 4 indicate any tax withholding or sales?

No tax withholding or sale transactions are reported in this Form 4. The transaction summary shows one derivative exercise for 154 shares and no sell, gift, or tax withholding entries, indicating a straightforward RSU-to-share conversion.